Arend Mosterd

21PUBLICATIONS

69CO-AUTHORS

Cardiology (incl. cardiovascular diseases)AutoimmunityPredictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 10, 2026

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.

|May 10, 2026

Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial.

|Mar 13, 2026

Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial.

Peter van der Meer, Geert H D Voordes, Marlene A T Vijver

|Oct 28, 2025

Allopurinol, gout, and cardiovascular risk.

Jalina Jannink, Arend Mosterd, Aernoud T L Fiolet

|May 15, 2025

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

Niekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax

|May 02, 2025

Colchicine for secondary prevention of vascular events: a meta-analysis of trials.

Marc-André d'Entremont, Michiel H F Poorthuis, Aernoud T L Fiolet

Pageof 4

Frequent Collaborators

Jan H Cornel

Stefan M Nidorf

John W Eikelboom

Michiel Rienstra

Vincent L Aengevaeren

3 joint publications

Kevin Damman

3 joint publications

Jannick A N Dorresteijn

3 joint publications

Aernoud T L Fiolet

3 joint publications

Astrid Schut

3 joint publications

Peter van der Meer

Frequent Collaborators

Jan H Cornel

Stefan M Nidorf

John W Eikelboom

Michiel Rienstra